During the past decade, Midwest Physicians Group conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Midwest Physicians Group" are "Breast Cancer" (1 trials), "Breast Tumor" (1 trials), "Cancer of the Breast" (1 trials), "Estrogen Receptor- Negative Breast Cancer" (1 trials) and "HER2- Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Midwest Physicians Group" in a lesser frequency.

Most popular intervention types in "Midwest Physicians Group" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (1 trials), "Gemcitabine" (1 trials), "TF0023" (1 trials) and "nab-Paclitaxel" (1 trials). Other intervention names were less common.

The vast majority of trials in "Midwest Physicians Group" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Midwest Physicians Group". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Midwest Physicians Group, 1 suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Midwest Physicians Group, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".